Standard
In vivo efficacy of HD0471953 : A novel GPR119 agonist for the treatment of type 2 diabetes mellitus. / 'T Hart, L. M.; Fritsche, A.; Nijpels, G.; Van Leeuwen, N.; Donnelly, L. A.; Dekker, J. M.; Alssema, M.; Fadista, J.; Carlotti, F.; Gjesing, A. P.; Palmer, C. N.; Van Haeften, T. W.; Herzberg-Schäfer, S. A.; Simonis-Bik, A. M.; Houwing-Duistermaat, J. J.; Helmer, Q.; Deelen, J.; Guigas, B.; Hansen, T.; MacHicao, F.; Willemsen, G.; Heine, R. J.; Kramer, M. H.; Holst, J. J.; De Koning, E. J.; Häring, H. U.; Pedersen, O.; Groop, L.; De Geus, E. J.; Slagboom, P. E.; Boomsma, D. I.; Eekhoff, E. M.; Pearson, E. R.; Diamant, M.
In:
Diabetes Technology & Therapeutics, Vol. 17, 01.02.2015, p. S131-S133.
Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
'T Hart, LM, Fritsche, A, Nijpels, G, Van Leeuwen, N, Donnelly, LA, Dekker, JM, Alssema, M, Fadista, J, Carlotti, F, Gjesing, AP, Palmer, CN, Van Haeften, TW, Herzberg-Schäfer, SA, Simonis-Bik, AM, Houwing-Duistermaat, JJ, Helmer, Q, Deelen, J, Guigas, B, Hansen, T, MacHicao, F, Willemsen, G, Heine, RJ, Kramer, MH
, Holst, JJ, De Koning, EJ, Häring, HU, Pedersen, O, Groop, L, De Geus, EJ, Slagboom, PE, Boomsma, DI, Eekhoff, EM, Pearson, ER & Diamant, M 2015, '
In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus',
Diabetes Technology & Therapeutics, vol. 17, pp. S131-S133.
https://doi.org/10.1089/dia.2015.1514APA
'T Hart, L. M., Fritsche, A., Nijpels, G., Van Leeuwen, N., Donnelly, L. A., Dekker, J. M., Alssema, M., Fadista, J., Carlotti, F., Gjesing, A. P., Palmer, C. N., Van Haeften, T. W., Herzberg-Schäfer, S. A., Simonis-Bik, A. M., Houwing-Duistermaat, J. J., Helmer, Q., Deelen, J., Guigas, B., Hansen, T., ... Diamant, M. (2015).
In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus.
Diabetes Technology & Therapeutics,
17, S131-S133.
https://doi.org/10.1089/dia.2015.1514Vancouver
'T Hart LM, Fritsche A, Nijpels G, Van Leeuwen N, Donnelly LA, Dekker JM et al.
In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus.
Diabetes Technology & Therapeutics. 2015 Feb 1;17:S131-S133.
https://doi.org/10.1089/dia.2015.1514Author
'T Hart, L. M. ; Fritsche, A. ; Nijpels, G. ; Van Leeuwen, N. ; Donnelly, L. A. ; Dekker, J. M. ; Alssema, M. ; Fadista, J. ; Carlotti, F. ; Gjesing, A. P. ; Palmer, C. N. ; Van Haeften, T. W. ; Herzberg-Schäfer, S. A. ; Simonis-Bik, A. M. ; Houwing-Duistermaat, J. J. ; Helmer, Q. ; Deelen, J. ; Guigas, B. ; Hansen, T. ; MacHicao, F. ; Willemsen, G. ; Heine, R. J. ; Kramer, M. H. ; Holst, J. J. ; De Koning, E. J. ; Häring, H. U. ; Pedersen, O. ; Groop, L. ; De Geus, E. J. ; Slagboom, P. E. ; Boomsma, D. I. ; Eekhoff, E. M. ; Pearson, E. R. ; Diamant, M. / In vivo efficacy of HD0471953 : A novel GPR119 agonist for the treatment of type 2 diabetes mellitus. In: Diabetes Technology & Therapeutics. 2015 ; Vol. 17. pp. S131-S133.
Bibtex
@article{07fc7d0c394c40828fed36b74d77e54d,
title = "In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus",
author = "{'T Hart}, {L. M.} and A. Fritsche and G. Nijpels and {Van Leeuwen}, N. and Donnelly, {L. A.} and Dekker, {J. M.} and M. Alssema and J. Fadista and F. Carlotti and Gjesing, {A. P.} and Palmer, {C. N.} and {Van Haeften}, {T. W.} and Herzberg-Sch{\"a}fer, {S. A.} and Simonis-Bik, {A. M.} and Houwing-Duistermaat, {J. J.} and Q. Helmer and J. Deelen and B. Guigas and T. Hansen and F. MacHicao and G. Willemsen and Heine, {R. J.} and Kramer, {M. H.} and Holst, {J. J.} and {De Koning}, {E. J.} and H{\"a}ring, {H. U.} and O. Pedersen and L. Groop and {De Geus}, {E. J.} and Slagboom, {P. E.} and Boomsma, {D. I.} and Eekhoff, {E. M.} and Pearson, {E. R.} and M. Diamant",
year = "2015",
month = feb,
day = "1",
doi = "10.1089/dia.2015.1514",
language = "English",
volume = "17",
pages = "S131--S133",
journal = "Diabetes Technology & Therapeutics",
issn = "1520-9156",
publisher = "Mary AnnLiebert, Inc. Publishers",
}
RIS
TY - JOUR
T1 - In vivo efficacy of HD0471953
T2 - A novel GPR119 agonist for the treatment of type 2 diabetes mellitus
AU - 'T Hart, L. M.
AU - Fritsche, A.
AU - Nijpels, G.
AU - Van Leeuwen, N.
AU - Donnelly, L. A.
AU - Dekker, J. M.
AU - Alssema, M.
AU - Fadista, J.
AU - Carlotti, F.
AU - Gjesing, A. P.
AU - Palmer, C. N.
AU - Van Haeften, T. W.
AU - Herzberg-Schäfer, S. A.
AU - Simonis-Bik, A. M.
AU - Houwing-Duistermaat, J. J.
AU - Helmer, Q.
AU - Deelen, J.
AU - Guigas, B.
AU - Hansen, T.
AU - MacHicao, F.
AU - Willemsen, G.
AU - Heine, R. J.
AU - Kramer, M. H.
AU - Holst, J. J.
AU - De Koning, E. J.
AU - Häring, H. U.
AU - Pedersen, O.
AU - Groop, L.
AU - De Geus, E. J.
AU - Slagboom, P. E.
AU - Boomsma, D. I.
AU - Eekhoff, E. M.
AU - Pearson, E. R.
AU - Diamant, M.
PY - 2015/2/1
Y1 - 2015/2/1
UR - http://www.scopus.com/inward/record.url?scp=84923101546&partnerID=8YFLogxK
U2 - 10.1089/dia.2015.1514
DO - 10.1089/dia.2015.1514
M3 - Comment/debate
AN - SCOPUS:84923101546
VL - 17
SP - S131-S133
JO - Diabetes Technology & Therapeutics
JF - Diabetes Technology & Therapeutics
SN - 1520-9156
ER -
